Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Wyeth patents new 11-beta-HSD1 inhibitors

Jan. 5, 2011

Takeda discloses new agonists of free fatty acid FFA1 receptor

Jan. 5, 2011

Repros Therapeutics receives approval for phase IIb Androxal trial

Jan. 4, 2011

New antagonists of melanin-concentrating hormone MCH1 receptor identified

Jan. 4, 2011

Replacement of alpha-L-iduronidase at birth shows promise to treat mucopolysaccharidosis

Jan. 4, 2011

BioSante raises funds for phase III LibiGel program

Jan. 3, 2011

BioCryst Pharma begins phase IIb trial of BCX-4208 as add-on therapy for gout

Jan. 3, 2011

New antagonists of melanin-concentrating hormone MCH1 receptor claimed

Jan. 3, 2011

Recordati and Merck Serono to comarket pitavastatin calcium in France

Dec. 31, 2010

FDA approves Fortesta for hypogonadism

Dec. 31, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.